Literature DB >> 23765907

Bioactive luminescent transition-metal complexes for biomedical applications.

Dik-Lung Ma1, Hong-Zhang He, Ka-Ho Leung, Daniel Shiu-Hin Chan, Chung-Hang Leung.   

Abstract

The serendipitous discovery of the anticancer drug cisplatin cemented medicinal inorganic chemistry as an independent discipline in the 1960s. Luminescent metal complexes have subsequently been widely applied for sensing, bio-imaging, and in organic light-emitting diode applications. Transition-metal complexes possess a variety of advantages that make them suitable as therapeutics and as luminescent probes for biomolecules. It is thus highly desirable to develop new luminescent metal complexes that either interact with DNA through different binding modes or target alternative cellular machinery such as proteins as well as to provide a more effective means of monitoring disease progression. In this Review, we highlight recent examples of biologically active luminescent metal complexes that can target and probe a specific biomolecule, and offer insights into the future potential of these compounds for the investigation and treatment of human diseases.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  luminescence; metal complexes; theranostics; therapeutic agent; transition metals

Mesh:

Substances:

Year:  2013        PMID: 23765907     DOI: 10.1002/anie.201208414

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  45 in total

1.  Investigation on Optical and Biological Properties of 2-(4-Dimethylaminophenyl)benzothiazole Based Cycloplatinated Complexes.

Authors:  Rebeca Lara; Gonzalo Millán; M Teresa Moreno; Elena Lalinde; Elvira Alfaro-Arnedo; Icíar P López; Ignacio M Larráyoz; José G Pichel
Journal:  Chemistry       Date:  2021-10-07       Impact factor: 5.020

2.  Cyclometalated rhodium and iridium complexes with imidazole containing Schiff bases: Synthesis, structure and cellular imaging.

Authors:  Soumik Mandal; Dipak K Poria; Dipravath K Seth; Partho Sarothi Ray; Parna Gupta
Journal:  Polyhedron       Date:  2014-02-10       Impact factor: 3.052

3.  Substitution reactivity and structural variability induced by tryptamine on the biomimetic rhenium tricarbonyl complex.

Authors:  Frederick J F Jacobs; Gertruida J S Venter; Eleanor Fourie; Robin E Kroon; Alice Brink
Journal:  RSC Adv       Date:  2021-07-13       Impact factor: 4.036

4.  Iridium(III) Luminescent Probe for Detection of the Malarial Protein Biomarker Histidine Rich Protein-II.

Authors:  Keersten M Davis; Anna L Bitting; Christine F Markwalter; Westley S Bauer; David W Wright
Journal:  J Vis Exp       Date:  2015-07-07       Impact factor: 1.355

5.  A label-free luminescent switch-on assay for ATP using a G-quadruplex-selective iridium(III) complex.

Authors:  Ka-Ho Leung; Lihua Lu; Modi Wang; Tsun-Yin Mak; Daniel Shiu-Hin Chan; Fung-Kit Tang; Chung-Hang Leung; Hiu-Yee Kwan; Zhiling Yu; Dik-Lung Ma
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

6.  Computational simulation of vibrationally resolved spectra for spin-forbidden transitions.

Authors:  Franco Egidi; Marco Fusè; Alberto Baiardi; Julien Bloino; Xiaosong Li; Vincenzo Barone
Journal:  Chirality       Date:  2018-05-04       Impact factor: 2.437

Review 7.  Metallodrugs are unique: opportunities and challenges of discovery and development.

Authors:  Elizabeth J Anthony; Elizabeth M Bolitho; Hannah E Bridgewater; Oliver W L Carter; Jane M Donnelly; Cinzia Imberti; Edward C Lant; Frederik Lermyte; Russell J Needham; Marta Palau; Peter J Sadler; Huayun Shi; Fang-Xin Wang; Wen-Ying Zhang; Zijin Zhang
Journal:  Chem Sci       Date:  2020-11-12       Impact factor: 9.825

8.  Identification of an iridium(III) complex with anti-bacterial and anti-cancer activity.

Authors:  Lihua Lu; Li-juan Liu; Wei-chieh Chao; Hai-Jing Zhong; Modi Wang; Xiu-Ping Chen; Jin-Jian Lu; Ruei-nian Li; Dik-Lung Ma; Chung-Hang Leung
Journal:  Sci Rep       Date:  2015-09-29       Impact factor: 4.379

9.  Crystal structure of [5-bromo-2-(pyridin-2-yl-κN)phenyl-κC (1)](pentane-2,4-dionato-κ (2) O,O')platinum(II).

Authors:  Keito Fukuda; Tomoaki Sugaya; Koji Ishihara
Journal:  Acta Crystallogr E Crystallogr Commun       Date:  2015-09-30

10.  Cytotoxic effects of the compound cis-tetraammine(oxalato)ruthenium(III) dithionate on K-562 human chronic myelogenous leukemia cells.

Authors:  Flávia de Castro Pereira; Aliny Pereira de Lima; Cesar Augusto Sam Tiago Vilanova-Costa; Wanessa Carvalho Pires; Alessandra de Santana Braga Barbosa Ribeiro; Lucas Carlos Gomes Pereira; Luiz Alfredo Pavanin; Wagner Batista Dos Santos; Elisângela de Paula Silveira-Lacerda
Journal:  Springerplus       Date:  2014-06-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.